Twin Reno girls treated for rare disease

April 16, 2009

(AP) -- Twin 5-year-old girls living with a rare disease are among the first in the country being treated for their condition at a Reno hospital after the U.S. Food and Drug Administration granted special permission to use an experimental drug.

Addi and Cassi Hempel of Reno were admitted to Renown Regional Medical Center on Monday to get the experimental treatment for Niemann-Pick Type C disease.

The FDA recently cleared them for intravenous infusions of the drug cyclodextrin, a sugar compound that has been successful in laboratory studies.

The were diagnosed in October 2007 with NP-C. There's currently no known cure for the disease, which also is referred to as childhood Alzheimer's.

It causes cholesterol to build up and get trapped inside the cells, which leads to debilitating neurological and physical problems.

The process eventually slows down cells and leads to cell death. Most patients with NP-C don't live past their teens, according to the National Niemann-Pick Foundation.

The girls' parents, Hugh and Chris Hempel, said they're optimistic about the use of cyclodextrin - an additive in cholesterol-free foods that studies show also might help combat the HIV virus.

"I'm fairly confident, but the question is about the dosing. They're getting half the recommended dose," Hugh Hempel told the Reno Gazette-Journal.

"The FDA asked us to start slowly. So, there will be proving to the FDA that it's safe," he said.

Dr. Ron Browne of Sun Valley, Idaho has been a liaison between the FDA and some families with children living with NP-C. He said the Hempels got approved for cyclodextrin through the FDA "compassionate use" program. Their condition will be evaluated every few weeks.

"The FDA is usually cautious," Browne said. "There needs to be life-threatening situations where no other option is available."

The girls, who wear diapers, began losing their ability to speak several months ago, Chris Hempel said.

"They used to be able to sing nursery rhymes and say their names but they've regressed, like any neurological condition," Chris Hempel said. "We can understand what they want, and they're still taking in what we're saying."

Chris Hempel said staying positive is the only choice available.

"You have to be positive when you have kids in this situation," she said.

---

Information from: Reno Gazette-Journal, http://www.rgj.com

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 5 /5 (1 vote)


April 16, 2009 all stories

Comments: 0

5 /5 (1 vote)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories

  • Researchers identify compound that frees trapped cholesterol
    created Jan 26, 2009 | popularity not rated yet | comments 0
  • FDA approves skin cancer drug
    created Oct 13, 2006 | popularity not rated yet | comments 0
  • FDA approves antiretroviral drug
    created Aug 07, 2007 | popularity not rated yet | comments 0
  • FDA reviews diabetic and HIV medications
    created Mar 27, 2008 | popularity not rated yet | comments 0
  • FDA approves drug for autism irritability
    created Oct 13, 2006 | popularity not rated yet | comments 0



  • hide
  • Relevant PhysicsForums posts

Other News

Smaller is better for finger sensitivity

Medicine & Health / Neuroscience

created 1hour ago | popularity not rated yet | comments 0

People who have smaller fingers have a finer sense of touch, according to new research in the Dec. 16 issue of The Journal of Neuroscience. This finding explains why women tend to have better tactile acuity than men, becaus ...


Time for a new view of late-life dementia

Medicine & Health / Diseases

created 2 hours ago | popularity 4 / 5 (1) | comments 0

Two new studies published in the December 16, 2009 issue of the Journal of the American Medical Association point to the need for a broader scientific perspective on late-life dementia, according to an editorial in the sa ...


Drug for Alzheimer's disease does not appear to slow cognitive decline

Medicine & Health / Medications

created 2 hours ago | popularity not rated yet | comments 0

Although there were promising results in a phase 2 trial, patients with mild Alzheimer disease who received the drug tarenflurbil as part of a phase 3 trial did not have better outcomes on measures of cognitive decline or ...


CERN Colour X-ray Technology Set to Save Lives

Medicine & Health / Research

created 1hour ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Medical studies are soon to start with the MARS scanner, a revolutionary CT scanner developed by the University of Canterbury, New Zealand. The scanner, which incorporates technology developed at the world's ...


Cold war - Fighting the threat of latent TB

Cold war - Fighting the threat of latent TB (w/ Podcast)

Medicine & Health / Diseases

created 2 hours ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Scientists are making breakthroughs in studying the latent form of Mycobacterium tuberculosis. This work could revolutionise the treatment of TB.